Research programme: 1-tetradecanol complex - Imagenetix

Drug Profile

Research programme: 1-tetradecanol complex - Imagenetix

Alternative Names: 1-TDC; Cetylated monounsaturated fatty acid complex

Latest Information Update: 04 Feb 2011

Price : $50

At a glance

  • Originator Imagenetix
  • Class Fatty acids
  • Mechanism of Action Thromboxane A2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Periodontal disorders

Most Recent Events

  • 04 Feb 2011 Preclinical development is ongoing in USA
  • 04 Feb 2011 This programme is still available for licensing as of 04 Feb 2011. http://www.imagenetix.net/
  • 12 Aug 2009 Pharmacodynamics data from a preclinical trial in Periodontal disorders released by Imagenetix ,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top